Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review …

V Furer, C Rondaan, M Heijstek, S Van Assen, M Bijl… - RMD open, 2019 - rmdopen.bmj.com
Objectives The aims of this study were to update the evidence on the incidence and
prevalence rates of vaccine preventable infections (VPI) in patients with autoimmune …

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, N Agmon-Levin, S Van Assen… - RMD open, 2021 - rmdopen.bmj.com
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

[HTML][HTML] Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

M Crnkic Kapetanovic, T Saxne, G Jönsson… - Arthritis research & …, 2013 - Springer
Introduction The objective of the study was to investigate the impact of newer biologic
treatments including rituximab, abatacept and tocilizumab on antibody response following …

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

GE Fragoulis, E Nikiphorou, M Dey, SS Zhao… - Annals of the …, 2023 - ard.bmj.com
Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …

Antibody response is reduced following vaccination with 7‐valent conjugate pneumococcal vaccine in adult methotrexate‐treated patients with established arthritis …

MC Kapetanovic, C Roseman, G Jönsson… - Arthritis & …, 2011 - Wiley Online Library
Objective To study the influence of antiinflammatory treatments, including methotrexate
(MTX) and tumor necrosis factor (TNF) inhibitors, on antibody response following …

[HTML][HTML] Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different …

M Crnkic Kapetanovic, T Saxne, L Truedsson… - Arthritis Research & …, 2013 - Springer
Introduction The aim of this study was to explore the persistence of an antibody response 1.5
years after vaccination with 7-valent pneumococcal conjugate vaccine in patients with …

Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with …

MC Kapetanovic, C Roseman, G Jönsson… - Clinical …, 2011 - Springer
The objectives of the study were to compare antibody response in immunosuppressed
patients with rheumatoid arthritis (RA) after vaccination with heptavalent pneumococcal …

[HTML][HTML] The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal …

C Roseman, L Truedsson, MC Kapetanovic - Arthritis research & therapy, 2012 - Springer
Introduction The purpose of this research was to study the influence of cigarette smoking
and alcohol consumption on immune response to heptavalent pneumococcal conjugate …

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

V Dubovyk, GK Vasileiadis, T Fatima, Y Zhang… - RMD open, 2024 - rmdopen.bmj.com
Objective This report from the NORD-STAR (Nordic Rheumatic Diseases Strategy Trials and
Registries) trial aimed to determine if obesity is associated with response to conventional …